Holen Sie sich die Stockscreener-App
4.07
5.99%
0.23
Handel nachbörslich:
4.07
Schlusskurs vom Vortag:
$3.84
Offen:
$3.84
24-Stunden-Volumen:
420.09K
Relative Volume:
1.59
Marktkapitalisierung:
$152.53M
Einnahmen:
$147.12M
Nettoeinkommen (Verlust:
$-33.88M
KGV:
-3.8313
EPS:
-1.0623
Netto-Cashflow:
$2.63M
1W Leistung:
+7.39%
1M Leistung:
-41.52%
6M Leistung:
-40.58%
1J Leistung:
-23.06%
1-Tages-Spanne:
$3.79
$4.15
1-Wochen-Bereich:
$3.625
$4.15
52-Wochen-Spanne:
$3.625
$8.9799
Lifecore Biomedical Inc Stock (LFCR) Company Profile
Firmenname
Lifecore Biomedical Inc
Sektor
Telefon
(952) 368-4300
Adresse
3515 LYMAN BOULEVARD, CHASKA
Compare LFCR vs TAK, ZTS, HLN, TEVA, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LFCR
Lifecore Biomedical Inc
|
4.07 | 143.91M | 147.12M | -33.88M | 2.63M | -1.0623 |
TAK
Takeda Pharmaceutical Co Adr
|
18.22 | 59.20B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
118.26 | 49.79B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
9.92 | 44.27B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.82 | 35.03B | 17.41B | 1.43B | 1.00B | 1.2182 |
UTHR
United Therapeutics Corp
|
559.65 | 24.75B | 3.18B | 1.33B | 1.04B | 27.90 |
Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-17 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2025-09-04 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2025-05-21 | Eingeleitet | William Blair | Outperform |
| 2024-09-05 | Eingeleitet | Craig Hallum | Buy |
| 2024-08-28 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2023-03-20 | Herabstufung | Stephens | Overweight → Equal-Weight |
Alle ansehen
Lifecore Biomedical Inc Aktie (LFCR) Neueste Nachrichten
Pomerantz LLP and The Rosen Law Firm, P.A. Announce Proposed Class Action Settlement on Behalf of Purchasers of Lifecore Biomedical, Inc. Securities - GlobeNewswire Inc.
LFCR.O Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
LFCR PE Ratio & Valuation, Is LFCR Overvalued - Intellectia AI
When Should You Buy Lifecore Biomedical, Inc. (NASDAQ:LFCR)? - Yahoo Finance
LFCR Should I Buy - Intellectia AI
Landec Corp. (US5147661046.SG) Stock Price, News, Quote & History - Yahoo! Finance Canada
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Lifecore Biomedical Transition period Earnings Call Transcript - MarketBeat
2026-04-02 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Shareholders to Learn More About the Investigation | NDAQ:LFCR | Press Release - Stockhouse
Lifecore Biomedical (LFCR) price target decreased by 25.71% to 6.63 - MSN
Momentum Shift: Can Lifecore Biomedical Inc continue delivering strong returns2026 Trade Ideas & Intraday High Probability Alerts - baoquankhu1.vn
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - accessnewswire.com
Buybacks Report: Is Lifecore Biomedical Inc a top pick in the sectorNew Guidance & Free Growth Oriented Trading Recommendations - baoquankhu1.vn
Claim your share of the $3.75M Lifecore Biomedical securities class action settlement - Claim Depot
Lifecore Biomedical Earnings Call Signals Profitable Shift - The Globe and Mail
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Lifecore signs two manufacturing deals with existing customer By Investing.com - Investing.com South Africa
Lifecore Biomedical (LFCR) to Release Earnings on Thursday - MarketBeat
Lifecore Biomedical, Inc. Common Stock (LFCR) Stock Price Today & Analysis - Gotrade
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Lifecore Biomedical Inks Two New Agreements with Existing US Customer - contractpharma.com
Lifecore signs two manufacturing deals with existing customer - Investing.com
Lifecore Biomedical Signs Two New Agreements with Existing U.S. Biopharmaceutical Customer - The Manila Times
LFCR: Barrington Research Maintains Outperform Rating with $5.50 Price Target | LFCR Stock News - gurufocus.com
Lifecore Biomedical (NASDAQ:LFCR) Earns Outperform Rating from Barrington Research - marketbeat.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biomedical, Inc. (LFCR) And Encourages Investors to Connect - accessnewswire.com
2026-03-24 | Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biomedical, Inc. (LFCR) And Encourages Investors to Connect | NDAQ:LFCR | Press Release - Stockhouse
Lifecore Biomedical signs third site transfer deal in five months By Investing.com - Investing.com Australia
Lifecore Biomedical Signs Commercial Manufacturing Services Agreement with Medical Aesthetics Company - MarketScreener
Lifecore Biomedical signs third site transfer deal in five months - Investing.com
Lifecore Biomedical Signs Commercial Site Transfer Agreement with Leading Medical Aesthetics Company - globenewswire.com
Published on: 2026-03-23 12:54:24 - baoquankhu1.vn
Lifecore stock sinks as delayed launches push growth further out - MSN
2026-03-22 | Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Stockholders to Inquire about Securities Investigation | NDAQ:LFCR | Press Release - Stockhouse
Aug Summary: Is Lifecore Biomedical Inc a strong candidate for buy and holdEarnings Overview Summary & Weekly Stock Performance Updates - baoquankhu1.vn
Rally Mode: Is Lifecore Biomedical Inc a top pick in the sector2026 Analyst Calls & High Accuracy Investment Signals - baoquankhu1.vn
Lifecore Biomedical CEO: Standalone CDMO Shift Complete, Utilization to Hit 60% by 2029 - MarketBeat
Analysts Offer Insights on Healthcare Companies: Neurosense Therapeutics Ltd. (NRSN), Structure Therapeutics, Inc. Sponsored ADR (GPCR) and Lifecore Biomedical (LFCR) - The Globe and Mail
Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biomedical, Inc. (LFCR) And Encourages Stockholders to Connect - ACCESS Newswire
Lifecore Biomedical at KeyBanc Forum: Strategic Transformation Insights By Investing.com - Investing.com Canada
Lifecore Biomedical at KeyBanc Forum: Strategic Transformation Insights - Investing.com
Lifecore Biomedical (NASDAQ:LFCR) Releases Quarterly Earnings Results, Misses Expectations By $0.05 EPS - MarketBeat
Lifecore Biomedical (NASDAQ:LFCR) Upgraded to Outperform at Barrington Research - MarketBeat
Why Is Lifecore Stock Sinking Tuesday?Lifecore Biomedical (NASDAQ:LFCR) - Benzinga
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Craig-Hallum Sticks to Its Buy Rating for Lifecore Biomedical (LFCR) - The Globe and Mail
Green Dot Corporation Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses - GlobeNewswire Inc.
Lifecore Biomedical (LFCR) Q4 Loss Narrows To US$2 Million Reinforcing Bullish Margin Narratives - simplywall.st
Lifecore Biomedical earnings missed, revenue fell short of estimates By Investing.com - Investing.com Canada
Lifecore Biomedical Shareholders Are Encouraged to Reach - GlobeNewswire
Finanzdaten der Lifecore Biomedical Inc-Aktie (LFCR)
Umsatz
Nettogewinn
Free Cashflow
ENV
Lifecore Biomedical Inc-Aktie (LFCR) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| English Aron R. | 10% Owner |
May 28 '25 |
Sale |
7.12 |
150,419 |
1,071,555 |
264,180 |
| English Aron R. | 10% Owner |
May 23 '25 |
Sale |
6.75 |
96,137 |
649,386 |
1,554,103 |
| English Aron R. | 10% Owner |
May 13 '25 |
Sale |
7.00 |
12,334 |
86,353 |
1,650,240 |
| English Aron R. | 10% Owner |
May 12 '25 |
Sale |
7.03 |
45,698 |
321,426 |
1,662,574 |
| English Aron R. | 10% Owner |
May 08 '25 |
Sale |
7.00 |
5,098 |
35,693 |
1,708,972 |
| English Aron R. | 10% Owner |
May 09 '25 |
Sale |
7.00 |
700 |
4,900 |
1,708,272 |
| English Aron R. | 10% Owner |
May 05 '25 |
Sale |
7.08 |
24,543 |
173,831 |
1,730,618 |
| English Aron R. | 10% Owner |
May 07 '25 |
Sale |
7.01 |
15,847 |
111,099 |
1,714,070 |
| English Aron R. | 10% Owner |
May 06 '25 |
Sale |
7.05 |
701 |
4,940 |
1,729,917 |
1.35%
0.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):